Gelesis Revenue and Competitors
Estimated Revenue & Valuation
- Gelesis's estimated annual revenue is currently $11.9M per year.
- Gelesis's estimated revenue per employee is $155,000
- Gelesis's total funding is $312.8M.
Employee Data
- Gelesis has 77 Employees.
- Gelesis grew their employee count by -37% last year.
Gelesis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and Founder | Reveal Email/Phone |
2 | Head Corporate Communications & Investor Relations | Reveal Email/Phone |
3 | Head Human Resources, Talent Acquisition, & IT | Reveal Email/Phone |
4 | EVP Endocrinology and Metabolism | Reveal Email/Phone |
5 | SVP | Reveal Email/Phone |
6 | VP BOD and Finance Director | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Chief Commercial & Operating Officer | Reveal Email/Phone |
9 | Finance and Procurement Manager | Reveal Email/Phone |
10 | QA Manager | Reveal Email/Phone |
Gelesis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Gelesis?
Gelesis is a registrational-stage biotechnology company developing a novel category of first-in-class therapies for weight loss and GI-related diseases. Our platform uses a clinically validated hydrogel technology composed of naturally derived building blocks. The Gelesis portfolio includes a product for obesity and overweight and a pipeline with potential therapies for Non-alcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH), Type 2 diabetes and Chronic Idiopathic Constipation (CIC). Gelesis is headquartered in Boston, Mass. and was founded by PureTech Health and a group of leading obesity researchers. Gelesis is led by a strong management team, with expertise in medicine, materials science, manufacturing and commercialization. Our scientific advisory board and clinical advisors are leading experts in obesity and chronic disease. Community guidelines: http://bit.ly/2Q8VfUG
keywords:Biotechnology
$312.8M
Total Funding
77
Number of Employees
$11.9M
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gelesis News
Gelesis' Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species...
Gelesis Holdings Inc (GLS) stock has risen 9.73% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.
The Company is evaluating and investigating its technology in GI-related diseases. Gelesis consummated a business combination with an SPAC in...
Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for the company’s first commercial product for weight management, Plenity®. Plenity was initially made available through a beta launch in 2020, and demand quickly outpa ...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, announced today that its Founded Entity, Gelesis, Inc. (“Gelesis”) received a $30 million fully paid pre-order for the company’s first commercial product for weight management, ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.6M | 77 | -8% | N/A |
#2 | $15M | 77 | 0% | N/A |
#3 | $22.3M | 77 | 3% | N/A |
#4 | $13.9M | 77 | 15% | N/A |
#5 | $11.9M | 77 | N/A | N/A |